About SPECT
SPECT or single-photon emission computed tomography is a nuclear medicine tomographic imaging technique that involves the generation of images using gamma radiation. This technique is used for diagnosing, monitoring, and treating various diseases related to oncology, neurology, cardiology, and other infectious diseases.
Technavio’s analysts forecast the global SPECT market to grow at a CAGR of 5.46% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global SPECT market for 2017-2021. To calculate the market size, the report considers the new installations/shipments/sales/volume/value and retrofit/replacement/spares/aftermarket/services market.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global SPECT Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GE Healthcare
• Philips Healthcare
• Siemens Healthineers
Other prominent vendors
• Bruker
• Digirad
• Esaote
• inviCRO
• LambdaSpect
• Mediso Medical Imaging Systems
• MR Solutions
• TriFoil Imaging
Market driver
• Growing adoption of SPECT/CT hybrid imaging system
• For a full, detailed list, view our report
Market challenge
• Potential complications associated with cardiac surgery
• For a full, detailed list, view our report
Market trend
• Growing focus on development of PET/MR hybrid imaging systems
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by application
• Cardiology
• Oncology
• General imaging
• Neurology
PART 07: Market segmentation by product
• Standalone SPECT
• Hybrid SPECT
PART 08: Market segmentation by end-user
• Hospitals
• Diagnostic centers and clinics
• Academic and research centers
PART 09: Geographical segmentation
• SPECT market in the Americas
• SPECT market in EMEA
• SPECT market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments
PART 12: Market trends
• Growing focus on development of PET/MR hybrid imaging systems
• Growing research activities to widen the applications of hybrid imaging
• Growing focus on emerging economies
PART 13: Vendor landscape
• Competitive landscape analysis
PART 14: Key vendor analysis
• GE Healthcare
• Philips Healthcare
• Siemens Healthineers
• Key company to watch
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global SPECT market: Market overview
Exhibit 02: Global SPECT market 2016-2021 ($ billions)
Exhibit 03: Factors impacting market growth of SPECT scanning systems
Exhibit 04: Five forces analysis
Exhibit 05: Global SPECT market segmentation by application area 2016 (%)
Exhibit 06: Global SPECT market for cardiology: Market overview
Exhibit 07: Global SPECT market for cardiology 2016-2021 ($ billions)
Exhibit 08: Global SPECT market for oncology: Market overview
Exhibit 09: Global SPECT market for oncology 2016-2021 ($ billions)
Exhibit 10: Global SPECT market for general imaging: Market overview
Exhibit 11: Global SPECT market for general imaging 2016-2021 ($ billions)
Exhibit 12: Global SPECT market for neurology: Market overview
Exhibit 13: Global SPECT market for neurology 2016-2021 ($ billions)
Exhibit 14: Market segmentation of SPECT by product type 2016
Exhibit 15: Global standalone SPECT: Market overview
Exhibit 16: Product offerings: Standalone SPECT
Exhibit 17: Global standalone SPECT market: Market impact and assessment 2016
Exhibit 18: Global standalone SPECT market 2016-2021 ($ billions)
Exhibit 19: Global hybrid SPECT: Market overview
Exhibit 20: Product offerings: Hybrid SPECT
Exhibit 21: Global hybrid SPECT market: Market impact and assessment 2016
Exhibit 22: Global hybrid SPECT market 2016-2021 ($ billions)
Exhibit 23: Global SPECT market by end-user 2016 (%)
Exhibit 24: Global SPECT market by geographical segmentation 2016 (%)
Exhibit 25: SPECT market in Americas: Market overview
Exhibit 26: SPECT market in Americas 2016-2021 ($ billions)
Exhibit 27: Total number of gamma cameras 2013-2015
Exhibit 28: SPECT market in EMEA: Market overview
Exhibit 29: SPECT market in EMEA 2016-2021 ($ billions)
Exhibit 30: SPECT market in APAC: Market overview
Exhibit 31: SPECT market in APAC 2016-2021 ($ billions)
Exhibit 32: Statistics for epilepsy in leading countries
Exhibit 33: Impact of drivers
Exhibit 34: Impact of challenges
Exhibit 35: Competitive structure analysis of global SPECT market 2016
Exhibit 36: Competitive landscape analysis of global SPECT market 2016
Exhibit 37: Strategic factors determining success for leading companies in global SPECT market
Exhibit 38: GE Healthcare: Key highlights
Exhibit 39: GE Healthcare: Strength assessment
Exhibit 40: GE Healthcare: Strategy assessment
Exhibit 41: GE Healthcare: Opportunity assessment
Exhibit 42: Philips Healthcare: Key highlights
Exhibit 43: Philips Healthcare: Strength assessment
Exhibit 44: Philips Healthcare: Strategy assessment
Exhibit 45: Philips Healthcare: Opportunity assessment
Exhibit 46: Siemens Healthineers: Key highlights
Exhibit 47: Siemens Healthineers: Strength assessment
Exhibit 48: Siemens Healthineers: Strategy assessment
Exhibit 49: Siemens Healthineers: Opportunity assessment
Exhibit 50: Toshiba Medical System: Key highlights
Exhibit 51: Toshiba Medical System: Strength assessment
Exhibit 52: Toshiba Medical System: Strategy assessment
Exhibit 53: Toshiba Medical System: Opportunity assessment
